Europe/Asia USA
Bachem AG Bachem Americas, Inc.
Hauptstrasse 144 3132 Kashiwa Street
4416 Bubendorf - Switzerland Torrance, CA 90505 - USA
Tel +41 61 935 2323 Tel +1 888 422 2436
Fax +41 61 935 2325 +1 888 4BACHEM
E-mail sales.ch@bachem.com +1 310 539 4171
  Fax +1 310 539 9428
  E-mail sales.us@bachem.com

TESTIMONIALS & PARTNERSHIPS

Testimonials & Partnerships

21. Jun 2016

AXON Neuroscience

“We are really proud on our end that we‘ve been able together with Bachem team reach such a success...

more
28. Jul 2015

Sinopharm Chemical Reagent Co., Ltd.

Bachem and Sinopharm Chemical Reagent Co., Ltd. sign contract for distributionship of research...

more
03. Jun 2014

Imugene Limited

Dr Nick Ede, Executive Director Imugene said, "Over my 25 years in the global peptide community from...

more
12. Aug 2011

Soricimed BioPharma Inc.

"As President and CEO of an emerging biopharmaceutical company, the selection process of a GMP API...

more
24. Jun 2011

ISA Pharmaceuticals B.V.

“When entering phase III with our lead product, we want to work with the best in class to assure...

more
12. Jan 2011

Theratechnologies, Inc.

"Theratechnologies is very pleased to be working with Bachem as a supplier of Tesamorelin. The...

more
27. Jun 2009

Abbott’s Supplier Excellence Award

Bachem Receives Abbott’s Supplier Excellence Award On Monday April 27, 2009, Abbott presented its...

more
27. Jun 2009

Abbott’s Supplier Excellence Award

Bachem Receives Abbott’s Supplier Excellence Award On Monday April 27, 2009, Abbott presented its...

more
31. Mar 2009

Debiopharm

Bachem and Debiopharm sign follow-up contract for long-term supply of Triptorelin Pamoate Bachem...

more
31. Mar 2009

Debiopharm

Bachem and Debiopharm sign follow-up contract for long-term supply of Triptorelin Pamoate Bachem...

more
28. Jan 2009

Bionor Immuno

Bionor Immuno and Bachem sign agreement on supply of active ingredients and finished dosage forms...

more
28. Jan 2009

Bionor Immuno

Bionor Immuno and Bachem sign agreement on supply of active ingredients and finished dosage forms...

more
10. Apr 2008

Action Pharma

Action Pharma and Bachem cooperate on AP214 - now ready to enter Phase 2 clinical trialsAction...

more
30. May 2007

Intercell

Bachem and Intercell agree long-term supply contract for peptide component of vaccine adjuvant...

more
09. May 2007

Neuren

Neuren and Bachem continue close collaboration on Glypromate® - Neuren’s lead product now in phase...

more
09. Mar 2006

Swedish Orphan International

Swedish Orphan International and Bachem conclude long-term supply agreement for nitisinone Bachem...

more
18. Mar 2004

Jerini

Jerini and Bachem announce collaboration for Icatibant production Jerini AG and Bachem AG today...

more